Enjoy complimentary customisation on priority with our Enterprise License!
The global cattle healthcare market size is forecast to increase by USD 4.47 billion, at a CAGR of 8.91% between 2023 and 2028.
There has been a growing awareness among farmers on the importance of preventive healthcare measures across the globe. In addition, with increasing access to information and education, farmers are becoming more proactive in managing the health and well-being of their herds. Moreover, they recognize that investing in preventive healthcare measures not only helps maintain the health and productivity of their cattle but also reduces the risk of disease outbreaks and associated economic losses. Therefore, there is a growing adoption of preventive healthcare strategies among farmers worldwide. Hence, such factors are positively impacting the market.
To learn more about this report, Download Report Sample
The beef cattle segment is estimated to witness significant growth during the forecast period. Beef cattle healthcare comprises a range of practices aimed at ensuring the well-being and productivity of cattle raised for meat production. In addition, one fundamental aspect of beef cattle healthcare is disease prevention, which involves implementing vaccination programs to protect against common illnesses such as respiratory diseases, clostridial infections, and reproductive disorders.
Get a glance at the market contribution of various segments Download PDF Sample
The beef cattle segment was the largest segment and was valued at USD 3.70 billion in 2018. Moreover, proper nutrition is crucial for maintaining the overall health and growth of beef cattle, with balanced diets formulated to meet their specific nutritional requirements at various stages of life, including grazing, feedlot finishing, and breeding. In addition, regular health monitoring and management practices, such as parasite control and hoof care, are essential to detect and address potential health issues before they escalate. Furthermore, reproductive health management plays a major role in beef cattle healthcare, encompassing breeding programs, pregnancy detection, and calving assistance to ensure optimal reproductive performance and herd fertility. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
The global market provides a broad range of pharmaceutical products aimed at ensuring the well-being and productivity of cattle worldwide. In addition, these products encompass a variety of categories, including vaccines, antibiotics, parasiticides, and reproductive health solutions. Moreover, vaccines play a crucial role in preventing infectious diseases such as bovine respiratory disease (BRD) and foot-and-mouth disease (FMD), helping to safeguard the health of cattle populations. In addition, reproductive health solutions, including hormone therapies and fertility treatments, are essential for maintaining herd fertility and maximizing breeding efficiency. Hence, such factors are fuelling the growth of the pharmaceutical segment which in turn drives the market growth during the forecast period.
The global market offers a wide array of feed additives designed to improve the health, growth, and productivity of cattle. In addition, these feed additives encompass various categories, including vitamins, minerals, amino acids, probiotics, prebiotics, enzymes, and growth promoters. Moreover, vitamins and minerals are essential for maintaining overall health and supporting various physiological functions in cattle. In addition, amino acids play a crucial role in protein synthesis and muscle development, while probiotics and prebiotics help promote a healthy digestive system and improve nutrient absorption. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market in North America is growing rapidly due to several factors. For example, the region's increased ownership, along with increased awareness of animal welfare, has led to in a surge in demand for effective healthcare solutions. In addition, veterinary clinics and hospitals are implementing improved cattle healthcare products and services to improve the health of cattle. Moreover, the incidence of chronic illnesses in aging cattle contributes to the growing regional market. Furthermore, the substantial presence of leading market companies in North America, including Zoetis Inc., Elanco Animal Health Inc., and Boehringer Ingelheim International GmbH, contributes to the vitality of the regional market. Hence, such factors are driving the market growth in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Biozyme Inc: The company offers cattle healthcare products such as AO Biotics Amaferm, AO Biotics EQE and VitaFerm.
Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., IDEXX Laboratories Inc., ImmuCell Corp., Indian Immunologicals Ltd., Innovative Diagnostics, International Health Care Ltd., Kyoritsuseiyaku Corp., Merck and Co. Inc., Norbrook Laboratories Ltd., Phibro Animal Health Corp., Thermo Fisher Scientific Inc., Vamso Biotec Pvt. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Zovix Pharmaceuticals
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The rising burden of cattle diseases is notably driving the market growth. Cattle are susceptible to a broad range of diseases, such as respiratory infections, gastrointestinal disorders, reproductive issues, and parasitic infestations, among others. In addition, these diseases not only pose health risks to individual animals but also have economic implications for farmers, including reduced productivity, increased mortality rates, and treatment costs.
Moreover, as global populations continue to grow, the demand for beef and dairy products is increasing, leading to the expansion of farming operations worldwide. In addition, factors such as poor sanitation, inadequate nutrition, and stress can exacerbate disease susceptibility among herds, further increasing the burden of diseases. Hence, such factors are driving the market growth during the forecast period.
The growing trend of telemedicine in veterinary care facilitates is an emerging trend in the market. The global market has witnessed a significant rise in telemedicine adoption, which is revolutionizing the way veterinary care is offered. In addition, telemedicine offers remote consultations and monitoring, allowing pet owners to seek healthcare guidance without having to make in-person visits.
Moreover, this approach has gained traction, particularly with the rising use of digital platforms and mobile apps developed for veterinary telemedicine services. For example, offerings such as Vetster in Canada and TeleVet in Texas provide virtual consultations in which pet owners may discuss pain management concerns with veterinary doctors in real-time, resulting in timely treatments. Hence, such factors are driving the market growth during the forecast period.
The problem in disease management of cattle is a major challenge hindering market growth. Several cattle are prone to a wide range of infectious and non-infectious diseases, which can have detrimental effects on herd health, productivity, and profitability. In addition, disease outbreaks not only result in economic losses for farmers through reduced milk production, decreased weight gain, and increased mortality rates but also incur additional costs associated with veterinary treatments and disease control measures.
Moreover, one of the primary challenges in disease management is the prevention and control of infectious diseases. In addition, cattle are often raised in high-density environments, including feedlots and intensive farming operations, which can facilitate the spread of infectious pathogens. Furthermore, factors such as poor sanitation, inadequate biosecurity measures, and stressors such as transportation and commingling can further exacerbate disease transmission within herds. Hence, such factors are hindering the market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market report forecasts market growth by revenue at global, regional & country levels and provides a market growth analysis of the latest market trends and growth opportunities from 2018 to 2028.
The market plays a crucial role in the pharmaceutical supply chain, supporting diagnostic and treatment procedures. As global economies reopen, trade in veterinary products and services gains momentum. Robust research and development (R&D) expenditure contribute to advancements in the cattle health sector, addressing issues such as mastitis—a common inflammation of the mammary gland in bovines and buffaloes. The prevalence of clinical mastitis necessitates the consumption of drugs and medical devices. The market's vitality is evident in the value and volume of animal product production. Ongoing efforts involve the launch of new and innovative products, providing effective treatment for cattle, including solutions for lumpy skin disease. Challenges, such as insufficient infrastructure and funding, underscore the importance of public and private organizations, veterinarians, and high-quality, low-dose X-rays. Initiatives for economical, adaptable, and simple-to-use diagnostic imaging systems, including open-bore CT scanners, demonstrate the market's commitment to improving cattle healthcare.
As global economies undergo reopening, the cattle healthcare market experiences significant growth, driven by government initiatives and support from animal welfare associations. This expansion is evident in the increased production of animal products, contributing to the vitality of livestock and poultry production. The market is characterized by ongoing product launches, showcasing innovations in veterinary services. However, challenges persist, including a lack of infrastructure and the associated costs of animal testing. To address these issues, there is a notable focus on introducing veterinary services equipped with advanced diagnostic tools such as CT scans and magnetic resonance imaging. The emphasis on developing simple-to-install systems underscores the importance of infrastructural support. Overall, these initiatives and product launches demonstrate a collective commitment to enhancing cattle healthcare and addressing the evolving needs of the industry.
Cattle Healthcare Market Scope |
|
Report Coverage |
Details |
Page number |
169 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.91% |
Market Growth 2024-2028 |
USD 4.47 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
7.53 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, France, Germany, India, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Biozyme Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., IDEXX Laboratories Inc., ImmuCell Corp., Indian Immunologicals Ltd., Innovative Diagnostics, International Health Care Ltd., Kyoritsuseiyaku Corp., Merck and Co. Inc., Norbrook Laboratories Ltd., Phibro Animal Health Corp., Thermo Fisher Scientific Inc., Vamso Biotec Pvt. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Zovix Pharmaceuticals |
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.